Serum paraoxonase and arylesterase activities in patients with pulmonary tuberculosis

Pathophysiology

Volumn 18, Issue 2, 2011, Pages 117-120

  Naderi, Mohamamd ^a   Hashemi, Mohammad ^b   Komijani Bozchaloei, Fatemeh ^a   Moazeni Roodi, Abdolkarim ^a   Momenimoghaddam, Mohammadamin ^c  

^a ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c UNIVERSITY OF SISTAN AND BALUCHESTAN   (Iran)

Author keywords

Arylesterase; Non pulmonary diseases; Paraoxonase; Pulmonary tuberculosis

Indexed keywords

ARYLDIALKYLPHOSPHATASE; ARYLESTERASE;

ADULT; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; HUMAN; INFLAMMATION; LUNG DISEASE; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; OXIDATION; PRIORITY JOURNAL;

EID: 79952041231     PISSN: 09284680     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pathophys.2010.05.002     Document Type: Article

References (19)

1. Dye C., Scheele S., Dolin P., Pathania V., Raviglione M.C. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA 1999, 282:677-686.
2. Mackness M.I., Arrol S., Durrington P.N. Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein. FEBS Lett. 1991, 286:152-154.
3. Jayakumari N., Thejaseebai G. High prevalence of low serum paraoxonase-1 in subjects with coronary artery disease. J. Clin. Biochem. Nutr. 2009, 45:278-284.
4. Mackness M.I., Harty D., Bhatnagar D., Winocour P.H., Arrol S., Ishola M., et al. Serum paraoxonase activity in familial hypercholesterolaemia and insulin-dependent diabetes mellitus. Atherosclerosis 1991, 86:193-199.
5. Abbott C.A., Mackness M.I., Kumar S., Boulton A.J., Durrington P.N. Serum paraoxonase activity, concentration, and phenotype distribution in diabetes mellitus and its relationship to serum lipids and lipoproteins. Arterioscler. Thromb. Vasc. Biol. 1995, 15:1812-1818.
6. Mohamadin A.M., Habib F.A., Elahi T.F. Serum paraoxonase 1 activity and oxidant/antioxidant status in Saudi women with polycystic ovary syndrome. Pathophysiology 2010, 17:189-196.
7. Varga E., Seres I., Harangi M., Sztanek F., Asztalos L., Locsey L., et al. Serum cystatin C is a determinant of paraoxonase activity in hemodialyzed and renal transplanted patients. Dis. Markers 2009, 26:141-148.
8. Selek S., Cosar N., Kocyigit A., Erel O., Aksoy N., Gencer M., et al. PON1 activity and total oxidant status in patients with active pulmonary tuberculosis. Clin. Biochem. 2008, 41:140-144.
9. Alavi-Naini R., Hashemi M., Mohagegh-Montazeri M., Sharifi-Mood B., Naderi M. Glutaraldehyde test for rapid diagnosis of pulmonary tuberculosis. Int. J. Tuberc. Lung Dis. 2009, 13:601-605.
10. Naderi M., Hashemi M., Kouhpayeh H., Ahmadi R. The status of serum procalcitonin in pulmonary tuberculosis and nontuberculosis pulmonary disease. J. Pak. Med. Assoc. 2009, 59:647-648.
11. Furlong C.E., Richter R.J., Seidel S.L., Motulsky A.G. Role of genetic polymorphism of human plasma paraoxonase/arylesterase in hydrolysis of the insecticide metabolites chlorpyrifos oxon and paraoxon. Am. J. Hum. Genet. 1988, 43:230-238.
12. Young I.S., Woodside J.V. Antioxidants in health and disease. J. Clin. Pathol. 2001, 54:176-186.
13. Knight J.A. Free radicals: their history and current status in aging and disease. Ann. Clin. Lab. Sci. 1998, 28:331-346.
14. Wiid I., Seaman T., Hoal E.G., Benade A.J., Van Helden P.D. Total antioxidant levels are low during active TB and rise with anti-tuberculosis therapy. IUBMB Life 2004, 56:101-106.
15. Kwiatkowska S., Piasecka G., Zieba M., Piotrowski W., Nowak D. Increased serum concentrations of conjugated diens and malondialdehyde in patients with pulmonary tuberculosis. Respir. Med. 1999, 93:272-276.
16. Lamsal M., Gautam N., Bhatta N., Toora B.D., Bhattacharya S.K., Baral N. Evaluation of lipid peroxidation product, nitrite and antioxidant levels in newly diagnosed and two months follow-up patients with pulmonary tuberculosis, Southeast Asian. J. Trop. Med. Public Health 2007, 38:695-703.
17. Aviram M., Rosenblat M. Paraoxonases 1, 2, and 3, oxidative stress, and macrophage foam cell formation during atherosclerosis development. Free Radic. Biol. Med. 2004, 37:1304-1316.
18. Rozenberg O., Aviram M. S-glutathionylation regulates HDL-associated paraoxonase 1 (PON1) activity. Biochem. Biophys. Res. Commun. 2006, 351:492-498.
19. May M.E., Spagnuolo P.J. Evidence for activation of a respiratory burst in the interaction of human neutrophils with Mycobacterium tuberculosis. Infect. Immun. 1987, 55:2304-2307.